Navigation Links
Xceed Molecular to Launch New Inflammation Xpress Chip(TM)for the Ziplex(R) Automated Gene-Expression Analysis System at Clinical Lab Expo 2008, Booth 2155
Date:7/29/2008

WASHINGTON and WELLESLEY, Mass., July 29 /PRNewswire/ -- Xceed Molecular, a pioneer in the development of cost-effective, easy-to-use gene-expression analysis systems, will launch its new Inflammation Xpress Chip, a pre-configured array for use with the company's Ziplex automated gene-expression analysis system, at the 2008 AACC/ASCLS Clinical Lab Expo (booth 2155). The Clinical Lab Expo opens today at Walter E. Washington Convention Center in Washington, DC.

"With our expanding portfolio of Xpress Chips, Xceed is creating another building block to accelerate the development of novel multiplex tests," said Xceed President and CEO David Deems. "Inflammation is a complex biological response to a wide range of tissue injuries, harmful pathogens, and disorders. This response is usually associated with increased levels of cytokines, cytokine receptors, adhesion molecules, and other immuno-regulatory factors. Our Inflammation Xpress Chip is a powerful tool to enable investigators to discover and characterize molecular profiles associated with inflammatory responses, to study the effects of therapeutics in mitigating immune responses, and to study auto-immune diseases in general. Expression changes in specific genes and pathways represented on the Inflammation Xpress Chip may help in monitoring patient responses to therapy or in predicting the ability of a therapeutic (e.g. Methotrexate, a TNF-alpha inhibitor, or a novel monoclonal antibody-based compound) to block disease-related inflammation events. The Inflammation Xpress Chip gene list was identified from scientific reports of genes differentially expressed in common inflammatory conditions.

At the core of the Ziplex System is the TipChip - a single-use disposable device consisting of a square Flow-Thru Chip(R) mounted to a polycarbonate tube. Unlike two-dimensional arrays, the unique 3D Flow-Thru Chip design enables active transport of targets to probes. Molecular interactions occur within the thr
'/>"/>

SOURCE Xceed Molecular
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million
2. CrossFire Beilstein Database Exceeds Ten Million Compounds
3. CNCA Exceeds Standards in Nutritional Supplement Quality, Protects Public
4. Center for Molecular Medicine Offers Xceed Ziplex(TM) Services to Research Community
5. AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $400,000
6. Cephalons 2007 Results Exceed Full Year Sales and Earnings Guidance
7. Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007
8. Kiwa Bio-Tech Year-End Revenues Increase 264% - Exceed $9.1 Million
9. Xceed Molecular Features Ziplex(R) Automated Gene-Expression System at the Biomarker World Congress, Booth 16
10. Xceed Molecular Grants Gen-Probe License to Xceeds Flow-Thru Chip(R) Technology for Multiplex Molecular Diagnostics
11. Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...HAYWARD, Calif., Nov. 6 Intarcia T...y on its ITCA 650 (DUROS® continuous delivery... diabetes at the Ninth Annual Diabetes Technology .../www.newscom.com/cgi-bin/prnh/20050301/SFTU126LOGO...natide Via ITCA 650 Lowers Plasma Glucose, HbA1c a...
(Date:11/5/2009)...GAITHERSBURG, Md., Nov. 5 /PRNewswire-FirstCall/ -...s financial results for the third quarter ended Se....6 million ($0.04 per share) for the three months ... $6.8 million ($0.08 per share) in the comparable ...er 30, 2009, GenVec,s net loss was $14.1 million (...
(Date:11/5/2009)...SAN DIEGO, Nov. 5 Imagen...oday that William Spencer, President and CEO of Im...t the 2nd annual LD MICRO Conference on Thursday, ...n Los Angeles. ,, About LD MICRO ,, LD MICRO...ses on finding undervalued companies in the micro-...
(Date:11/5/2009)...OMAHA, Neb., Nov. 5 Tran...nounced financial results for the quarter ended Se...are presented in the tables that follow. ,, Th... loss of $366,000 or $0.01 per share for the third...,000 or $0.01 per share for the third quarter of 2...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...ugal, December 8 , - Data Highlight The Eff...ty of Life and Depressive Symptoms With Zebinix(TM...from three phase III studies presented today at th...e, USA, show that,Zebinix(TM)(1) (eslicarbazepine ... significantly reduced the frequency of partial se...
... PHILADELPHIA, Dec. 8 GlaxoSmithKline,(LSE/NYSE: ...reviously announced,tender offer to purchase all o...bs Technologies, Inc. (Nasdaq: GNLB ), for $1.30...equired withholding taxes, until 12:00 midnight,ES...offer is further extended.,The tender offer was or...
...ation announces its focus on new Rapid-Fill ASF co...(PACT) products at the 2008 American Society of He...and Exhibition beginning today at the Orange Count...WOOD, Colo., Dec. 8 Baxa Corporation is featuring... Productivity and Compliance Tools (PACT), Exacta-...
Other Biology Technology:Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 2Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 3Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 4Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 5Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 6Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 7GlaxoSmithKline Extends Tender Offer for Genelabs Technologies, Inc. 2Baxa Features Rapid-Fill(TM) Colored Labels, PACT(TM) Products, Exacta-Mix(TM) 2400 Compounders and Abacus(TM) Software at the ASHP Mid-Year Clinical Meeting 2Baxa Features Rapid-Fill(TM) Colored Labels, PACT(TM) Products, Exacta-Mix(TM) 2400 Compounders and Abacus(TM) Software at the ASHP Mid-Year Clinical Meeting 3
(Date:11/8/2009)... WEST LAFAYETTE, Ind. - Researchers at Purdue Univ...g damaged nerve fibers in spinal cord injuries usi...ood shortly after an accident. , The synthetic "...t 60 nanometers in diameter, or roughly 100 times ... Researchers have been studying how to deliver dru...
(Date:11/6/2009)...ee-dwelling ants generally live in harmony with th... when they run out of space in their trees of choi...ees. , The research, published in the November i... document that ants bore into live trees, and it r...between ants and plants. , Ants and certain spec...
(Date:11/5/2009)...nt State University has been awarded a training gr...ience Foundation under its Integrative Graduation ...his is the first IGERT grant to be awarded to Kent...can Recovery and Reinvestment Act of 2009, runs th...hat focuses on environment aquatic resource sensin...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Ants are friendly to some trees, but not others 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2American Airlines Employees Raise 241 Million for American Cancer Society 56600 1American Airlines Employees Raise 241 Million for American Cancer Society 56600 2American Airlines Employees Raise 241 Million for American Cancer Society 56600 3Exotic Adventure and Clean Food 3A The Adventure Cookbook 56597 1Exotic Adventure and Clean Food 3A The Adventure Cookbook 56597 2Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 1Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 2Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 3Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 4Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 5Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 6Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 7Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 8Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 9
... Using a "clot buster" drug normally reserved for ... room doctors were able to double the number of pa...his sudden loss of heart function occurs in more t... 93 percent of them die. , "Clot-busting agents sh...tastrophic loss of heart function," said William P...
... It turns out that the sea slug isn,t really that ...study of this charismatic orange creature,s behavi...ril 2006 issue of The Biological Bulletin. , The ...nown as Tritonia diomedea, a nudibranch mollusc sp...mportant in laboratory studies of the how the brai...
... Acid rain, the environmental consequence of burni...s, has altered soils and reduced the number of sug... to a new study led by Cornell University research...aluable tree species in the eastern United States ...st-attracting fall colors. , The study, whose l...
Other Biology News:Clot-busting drug helps revive cardiac arrest patients 2The secret lives of sea slugs 2Acid rain causing decline in sugar maples, say researchers 2Acid rain causing decline in sugar maples, say researchers 3
Goat Anti-Human RELT / TNFRSF19L Polyclonal Antibody, Unconjugated from R&D Systems
Rabbit Anti-HOXD3 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Goat Anti-Mouse NOV / CCN3 Polyclonal Antibody, Unconjugated from R&D Systems
Rabbit Anti-Human SNAPAP Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Biology Products: